Testing Vespireit for chronic dizziness from autonomic dysfunction
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests a new medication called Vespireit (prolonged-release buspirone) for people with chronic dizziness caused by a problem with the autonomic nervous system. The study aims to see if the drug helps reduce dizziness and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with chronic dizziness or imbalance (functional vertigo) and your symptoms are linked to a problem with your autonomic nervous system (the part that controls automatic body functions like heart rate and blood pressure).
- You are not pregnant, breastfeeding, or planning pregnancy, and you agree to use an effective non-hormonal birth control method (if applicable) during the study and for 3 weeks after.
- You do not have serious heart problems, uncontrolled high blood pressure, epilepsy, Parkinson's disease, certain mental health conditions, or other major medical conditions listed in the eligibility criteria.
- You have not taken certain medications for dizziness or depression in the last 3 weeks, and you are willing to avoid them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how vestibular migraine is treated in real-life Chinese clinical practice. It may help researchers understand which treatments work best for people with this condition.
This trial tests if rimegepant can help reduce dizziness from vestibular migraine. It is for people who have tried at least one other preventive treatment without success and have frequent dizzy days.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests if a mild electrical stimulation to the inner ear can reduce dizziness and migraine symptoms. It involves six short sessions over two weeks.
This study tests a new combination pill (Viaca) that contains sildenafil and cabergoline. It aims to see how safe it is and how the body processes it, compared to taking each medicine separately. Healthy men aged 18 to 65 may be able to join.
This study is testing a device that may help reduce motion sickness and feelings of disorientation. Healthy people who do not usually get motion sickness are needed to participate.
Hear when a new Vertigo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.